(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY) announced the U.S. launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules USP, a therapeutic equivalent generic version of Librax. Dr. Reddy's Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP are available in one strength of 5 mg/2.5 mg capsules in bottle count sizes of 100.
The company noted that Librax brand and generic market had U.S. sales of approximately $105.9 million MAT for the most recent twelve months ending in July 2021.
Dr. Reddy's is an an integrated pharmaceutical company offering a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
